Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.
Digestive and Liver Disease（2018）
摘要
Our results indicate that ∆LS is a useful non-invasive marker for predicting HCC development after DAA treatment.
更多查看译文
关键词
Delta liver stiffness,Direct-acting antiviral agents,HCV,Hepatocellular carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要